4//SEC Filing
Reiss-Clark Cindy 4
Accession 0001127602-25-006123
CIK 0000105770other
Filed
Feb 19, 7:00 PM ET
Accepted
Feb 20, 9:16 PM ET
Size
13.2 KB
Accession
0001127602-25-006123
Insider Transaction Report
Form 4
Reiss-Clark Cindy
Chief Commercial Officer
Transactions
- Exercise/Conversion
Common Stock
2025-02-18$211.00/sh+246.162$51,940→ 5,130.508 total - Tax Payment
Common Stock
2025-02-18$211.00/sh−83.179$17,551→ 5,047.329 total - Award
Stock Option (Right to Buy)
2025-02-18+1,162→ 1,162 totalExercise: $211.00From: 2026-02-18Exp: 2035-02-18→ Common Stock (1,162 underlying) - Award
Rst. Stock Unit
2025-02-18+503→ 503 totalExercise: $0.00→ Common Stock (503 underlying)
Footnotes (1)
- [F1]This award vests in four equal installments beginning on February 18, 2026.
Issuer
WEST PHARMACEUTICAL SERVICES INC
CIK 0000105770
Entity typeother
Related Parties
1- filerCIK 0001916513
Filing Metadata
- Form type
- 4
- Filed
- Feb 19, 7:00 PM ET
- Accepted
- Feb 20, 9:16 PM ET
- Size
- 13.2 KB